Literature DB >> 35665862

BRD2 interconnects with BRD3 to facilitate Pol II transcription initiation and elongation to prime promoters for cell differentiation.

Chenlu Wang1, Qiqin Xu1, Xianhong Zhang2, Daniel S Day3, Brian J Abraham3,4, Kehuan Lun1, Liang Chen2, Jie Huang5, Xiong Ji6.   

Abstract

The bromodomain and extraterminal motif (BET) proteins are critical drug targets for diseases. The precise functions and relationship of BRD2 with other BET proteins remain elusive mechanistically. Here, we used acute protein degradation and quantitative genomic and proteomic approaches to investigate the primary functions of BRD2 in transcription. We report that BRD2 is required for TAF3-mediated Pol II initiation at promoters with low levels of H3K4me3 and for R-loop suppression during Pol II elongation. Single and double depletion revealed that BRD2 and BRD3 function additively, independently, or perhaps antagonistically in Pol II transcription at different promoters. Furthermore, we found that BRD2 regulates the expression of different genes during embryonic body differentiation processes by promoter priming in embryonic stem cells. Therefore, our results suggest complex interconnections between BRD2 and BRD3 at promoters to fine-tune Pol II initiation and elongation for control of cell state.
© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Keywords:  BET proteins; Cross-regulation; Embryonic body; RNA Pol II

Mesh:

Substances:

Year:  2022        PMID: 35665862     DOI: 10.1007/s00018-022-04349-4

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  58 in total

1.  The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription.

Authors:  Moon Kyoo Jang; Kazuki Mochizuki; Meisheng Zhou; Ho-Sang Jeong; John N Brady; Keiko Ozato
Journal:  Mol Cell       Date:  2005-08-19       Impact factor: 17.970

2.  Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4.

Authors:  Zhiyuan Yang; Jasper H N Yik; Ruichuan Chen; Nanhai He; Moon Kyoo Jang; Keiko Ozato; Qiang Zhou
Journal:  Mol Cell       Date:  2005-08-19       Impact factor: 17.970

3.  Distinct Roles of Brd2 and Brd4 in Potentiating the Transcriptional Program for Th17 Cell Differentiation.

Authors:  Ka Lung Cheung; Fan Zhang; Anbalagan Jaganathan; Rajal Sharma; Qiang Zhang; Tsuyoshi Konuma; Tong Shen; June-Yong Lee; Chunyan Ren; Chih-Hung Chen; Geming Lu; Matthew R Olson; Weijia Zhang; Mark H Kaplan; Dan R Littman; Martin J Walsh; Huabao Xiong; Lei Zeng; Ming-Ming Zhou
Journal:  Mol Cell       Date:  2017-03-03       Impact factor: 17.970

4.  Functions of BET proteins in erythroid gene expression.

Authors:  Aaron J Stonestrom; Sarah C Hsu; Kristen S Jahn; Peng Huang; Cheryl A Keller; Belinda M Giardine; Stephan Kadauke; Amy E Campbell; Perry Evans; Ross C Hardison; Gerd A Blobel
Journal:  Blood       Date:  2015-02-18       Impact factor: 22.113

Review 5.  The mechanisms behind the therapeutic activity of BET bromodomain inhibition.

Authors:  Junwei Shi; Christopher R Vakoc
Journal:  Mol Cell       Date:  2014-06-05       Impact factor: 17.970

6.  Suppression of inflammation by a synthetic histone mimic.

Authors:  Edwige Nicodeme; Kate L Jeffrey; Uwe Schaefer; Soren Beinke; Scott Dewell; Chun-Wa Chung; Rohit Chandwani; Ivan Marazzi; Paul Wilson; Hervé Coste; Julia White; Jorge Kirilovsky; Charles M Rice; Jose M Lora; Rab K Prinjha; Kevin Lee; Alexander Tarakhovsky
Journal:  Nature       Date:  2010-11-10       Impact factor: 49.962

7.  H2A.Z.1 Monoubiquitylation Antagonizes BRD2 to Maintain Poised Chromatin in ESCs.

Authors:  Lauren E Surface; Paul A Fields; Vidya Subramanian; Russell Behmer; Namrata Udeshi; Sally E Peach; Steven A Carr; Jacob D Jaffe; Laurie A Boyer
Journal:  Cell Rep       Date:  2016-01-21       Impact factor: 9.423

8.  RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia.

Authors:  Johannes Zuber; Junwei Shi; Eric Wang; Amy R Rappaport; Harald Herrmann; Edward A Sison; Daniel Magoon; Jun Qi; Katharina Blatt; Mark Wunderlich; Meredith J Taylor; Christopher Johns; Agustin Chicas; James C Mulloy; Scott C Kogan; Patrick Brown; Peter Valent; James E Bradner; Scott W Lowe; Christopher R Vakoc
Journal:  Nature       Date:  2011-08-03       Impact factor: 49.962

9.  Acute perturbation strategies in interrogating RNA polymerase II elongation factor function in gene expression.

Authors:  Bin Zheng; Yuki Aoi; Avani P Shah; Marta Iwanaszko; Siddhartha Das; Emily J Rendleman; Didi Zha; Nabiha Khan; Edwin R Smith; Ali Shilatifard
Journal:  Genes Dev       Date:  2021-01-14       Impact factor: 11.361

10.  Selective inhibition of BET bromodomains.

Authors:  Panagis Filippakopoulos; Jun Qi; Sarah Picaud; Yao Shen; William B Smith; Oleg Fedorov; Elizabeth M Morse; Tracey Keates; Tyler T Hickman; Ildiko Felletar; Martin Philpott; Shonagh Munro; Michael R McKeown; Yuchuan Wang; Amanda L Christie; Nathan West; Michael J Cameron; Brian Schwartz; Tom D Heightman; Nicholas La Thangue; Christopher A French; Olaf Wiest; Andrew L Kung; Stefan Knapp; James E Bradner
Journal:  Nature       Date:  2010-09-24       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.